Daiichi Sankyo press release (DSKYF): Q2 global revenue increased 19.7% year-over-year to 1.167 trillion yen, driven by the companyâs global oncology medicines. – Operating profit increased 34.4% year-over-year to 193.8 billion yen. – Full fiscal year 2026 guidance remains…
changed. Global revenue is anticipated